Mark For: GENCARE GENERIC HEALTHCARE® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 88839031 |
Registration Number | 7045585 |
Mark Literal Elements | GENCARE GENERIC HEALTHCARE |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | TRADEMARK |
Register | PRINCIPAL |
Current Location | TMO LAW OFFICE 115 2021-08-13 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Danielle Cohen, Esq. |
Attorney Docket Number | 16992.004 |
2018-11-00 | Date of First Use |
2018-11-01 | Date of First Use |
2018-11-01 | Date of Use In Commerce |
2020-03-18 | Application Filed |
2020-03-21 | Location: NEW APPLICATION PROCESSING |
2020-03-21 | Status: Live/Pending |
2020-03-21 | Transaction Date |
2021-08-13 | Location: TMO LAW OFFICE 115 |
2021-08-13 | Status: Suspension check completed. Application remains suspended. |
Party: | Pioneer Life Sciences LLC |
Address | Suite A 40E Cotters Lane East Brunswick, NEW JERSEY UNITED STATES 08816 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | NEW JERSEY |
Drawing | 2020-03-18 | |
Specimen | 2020-03-18 | |
TEAS Plus New Application | 2020-03-18 | |
XSearch Search Summary | 2020-06-10 | |
Offc Action Outgoing | 2020-06-15 | |
XSearch Search Summary | 2020-06-15 | |
Response to Office Action | 2020-11-11 | |
Specimen | 2020-11-11 | |
Amendment and Mail Process Complete | 2020-11-13 | |
Suspension Letter | 2020-11-13 | |
Final Action | 2022-05-31 | |
Notation to File | 2022-07-05 | |
Suspension Letter | 2022-07-05 | |
TEAS Response to Suspension Inquiry | 2022-11-14 | |
Notation to File | 2022-12-12 | |
Amendment and Mail Process Complete | 2023-01-13 | |
TRAM Snapshot of App at Pub for Oppostn | 2023-01-14 | |
Notice of Publication | 2023-02-01 | |
Notification Of Notice of Publication | 2023-02-01 | |
OG Publication Confirmation | 2023-02-21 | |
Notice of Registration-Notice | 2023-05-09 | |
Registration Certificate | 2023-05-09 |
IC 005. US 006 018 044 046 051 052. G & S: Herbal extracts for medical purposes; Herbal supplements; Laxatives; Nutraceuticals for the treatment of cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical antitussive-cold preparations; Vitamin supplements; Vitamin tablets; Dietary food supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Natural herbal supplements; Nutritional supplements; Probiotic supplements; Protein supplements. FIRST USE: 20181100. FIRST USE IN COMMERCE: 20181100
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Herbal extracts for medical purposes; Herbal supplements; Laxatives; Nutraceuticals for the treatment of cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical antitussive-cold preparations; Vitamin supplements; Vitamin tablets; Dietary food supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Natural herbal supplements; Nutritional supplements; Probiotic supplements; Protein supplements |
GS0051 | Herbal extracts for medical purposes; Herbal supplements; Laxatives; Nutraceuticals for the treatment of cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for cardiovascular, digestive, endocrine, integumentary, immune, lymphatic, musculoskeletal, nervous, renal, reproductive and respiratory conditions, disorders, and diseases; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for peripheral nervous system; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating asthma; Pharmaceutical antitussive-cold preparations; Vitamin supplements; Vitamin tablets; Dietary food supplements; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Natural herbal supplements; Nutritional supplements; Probiotic supplements; Protein supplements |
Description | Date | Proceeding Number |
---|---|---|
REGISTERED-PRINCIPAL REGISTER | 2023-05-09 | |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2023-05-09 | |
PUBLISHED FOR OPPOSITION | 2023-02-21 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-02-21 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-02-01 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-01-13 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-01-12 | 96338 |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-01-12 | 96338 |
ASSIGNED TO LIE | 2023-01-11 | 96338 |
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2022-11-14 | |
SUSPENSION LETTER WRITTEN | 2022-07-05 | 83706 |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2022-07-05 | |
LETTER OF SUSPENSION E-MAILED | 2022-07-05 | |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2022-05-31 | |
FINAL REFUSAL WRITTEN | 2022-05-31 | 83706 |
FINAL REFUSAL E-MAILED | 2022-05-31 | |
SUSPENSION CHECKED TO ATTORNEY FOR ACTION | 2022-05-09 | 88889 |
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | 2021-08-13 | 88889 |
SUSPENSION LETTER WRITTEN | 2020-11-13 | 83706 |
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2020-11-13 | 6332 |
LETTER OF SUSPENSION E-MAILED | 2020-11-13 | 6332 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-11-12 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-11-11 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-11-11 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-06-15 | 6325 |
NON-FINAL ACTION WRITTEN | 2020-06-15 | 83706 |
NON-FINAL ACTION E-MAILED | 2020-06-15 | 6325 |
ASSIGNED TO EXAMINER | 2020-06-10 | 83706 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-03-23 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2020-03-23 | |
NEW APPLICATION ENTERED IN TRAM | 2020-03-21 | |
NEW APPLICATION ENTERED | 2020-03-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.